Uranium Participation Reports Uranium Purchases and Net Asset Value at October 31, 2016

On October 31, 2016, the common shares of UPC closed on the TSX at a value of CAD$3.72, which represents a 12.39% premium to the net asset value per share of CAD$3.31.
Uranium Purchases
During October 2016, UPC completed a bought-deal financing and issued 5,200,000 common shares, at a price of CAD$3.85 per share, for gross proceeds of $20,020,000. The majority of the proceeds are expected to be used to fund the purchase of uranium. As of November 2, 2016, UPC has entered into agreements to purchase 560,000 pounds U₃O₈ at an average price of US$20.57 per pound, with deliveries expected during November 2016. As at October 31, 2016, the number of UPC common shares outstanding was 120,848,713.
About Uranium Participation Corporation
Uranium Participation Corporation is a company that invests substantially all of its assets in uranium oxide in concentrates (“U₃O₈“) and uranium hexafluoride (“UF₆“) (collectively “uranium”), with the primary investment objective of achieving appreciation in the value of its uranium holdings through increases in the uranium price. UPC provides investors with a unique opportunity to gain exposure to the price of uranium without the resource or project risk associated with investing in a traditional mining company. Additional information about Uranium Participation Corporation is available on SEDAR at www.sedar.com and on Uranium Participation Corporation’s website at www.uraniumparticipation.com.
Caution Regarding Forward-Looking Information
This press release contains certain forward-looking statements and forward-looking information that are based on the Company’s current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intent”, “estimate”, “anticipate”, “plan”, “should”, “believe” or “continue” or the negative thereof or variations thereon or similar terminology and include statements with respect to the use of proceeds for the Offering and the anticipated completion of uranium purchases.
By their very nature, forward-looking statements involve numerous factors, assumptions and estimates. A variety of factors, many of which are beyond the control of the Company, may cause actual results to differ materially from the expectations expressed in the forward-looking statement. These factors include, but are not limited to, changes in commodity prices and foreign exchange as well as the risk that the Company will not be successful in completing the purchase of additional U₃O₈ and/or UF₆ on terms satisfactory to the Company. For a description of the principal risks of the Company, see “Risk Factors” in the Company’s Annual Information Form dated May 11, 2016, a copy of which is available at www.sedar.com.
These and other factors should be considered carefully, and readers are cautioned not to place undue reliance on these forward-looking statements. Although management reviews the reasonableness of its assumptions and estimates, unusual and unanticipated events may occur which render them inaccurate. Under such circumstances, future performance may differ materially from those expressed or implied by the forward-looking statements. Except where required under applicable securities legislation, the Company does not undertake to update any forward-looking information statement.